https://www.prnewswire.com/news-releases/altheus-therapeutics-completes-treatment-portion-of-za201-a-phase-2-trial-of-zoenasa-for-ulcerative-colitis-247238221.html
Altheus Therapeutics completes treatment portion of ZA201, a Phase 2 trial of Zoenasa for...
/PRNewswire/ -- Altheus Therapeutics, Inc., announced completion of dosing in ZA201, a double-blind, active-controlled Phase 2 trial evaluating the efficacy...